1477 Results

People

  1. Motzer
    Motzer
  2. Hudis
    Hudis
  3. Aghajanian
    Aghajanian
  4. O'Reilly
    O'Reilly
  5. Kris
    Kris
  6. Scher
    Scher
  7. Panageas
    Panageas
  8. Saltz
    Saltz
  9. Schwartz
    Schwartz
  10. Kelsen
    Kelsen

Groups

  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)
  7. Epidemiology and Biostatistics (194)
  8. Biostatistics Service (169)
  9. Gastrointestinal Oncology Service (160)
  10. Population Sciences Research Program (158)
  1. "fatigue"
Formats
  1. Journal Article (1402)
  2. Review (38)
  3. Research Letter (13)
  4. Editorial (10)
  5. Conference Paper (5)
  6. Guidelines (4)
  7. Correspondence (3)
  8. Book Section (2)
Groups
  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)

More Groups

People
  1. Robert Motzer (85)
  2. Clifford Hudis (49)
  3. Carol Aghajanian (46)
  4. Eileen O'Reilly (46)
  5. Howard Scher (44)
  6. Mark Kris (44)

More People

Years
  1. 2025 (60)
  2. 2024 (132)
  3. 2023 (89)
  4. 2022 (46)
  5. 2021 (33)
  6. 2020 (85)

More Years

Publications
  1. Journal of Clinical Oncology (108)
  2. Clinical Cancer Research (82)
  3. Cancer (63)
  4. Lancet Oncology (50)
  5. Gynecologic Oncology (41)
  6. Annals of Oncology (37)

More Publications

Publishers
  1. Elsevier Inc. (244)
  2. Springer (133)
  3. American Society of Clinical Oncology (114)
  4. Elsevier Science, Inc. (108)
  5. Oxford University Press (101)
  6. American Association for Cancer Research (89)

More Publishers

Results (1477)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): A multicentre, multicohort, open-label, phase 1b trial
    Journal Article

    Naing, A.; Wong, D. J.; Infante, J. R.; Korn, W. M.; Aljumaily, R.; Papadopoulos, K. P.; Autio, K. A.; Pant, S.; Bauer, T. M.; Drakaki, A.; more...
    Lancet Oncology (2019)

    Fulltext@MSK | Save
  • Gilteritinib or chemotherapy for relapsed or refractory FLT3-mutated AML
    Journal Article

    Perl, A. E.; Martinelli, G.; Cortes, J. E.; Neubauer, A.; Berman, E.; Paolini, S.; Montesinos, P.; Baer, M. R.; Larson, R. A.; Ustun, C.; more...
    New England Journal of Medicine (2019)

    Fulltext@MSK | Save
  • A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer
    Journal Article

    McHugh, D.; Eisenberger, M.; Heath, E. I.; Bruce, J.; Danila, D. C.; Rathkopf, D. E.; Feldman, J.; Slovin, S. F.; Anand, B.; Chu, R.; more...
    Investigational New Drugs (2019)

    Fulltext@MSK | Save
  • Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: A pooled analysis
    Journal Article

    Antonia, S. J.; Borghaei, H.; Ramalingam, S. S.; Horn, L.; De Castro Carpeño, J.; Pluzanski, A.; Burgio, M. A.; Garassino, M.; Chow, L. Q. M.; Gettinger, S.; more...
    Lancet Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): A phase 3, multicentre, open-label, single-arm trial
    Journal Article

    Fleseriu, M.; Pivonello, R.; Elenkova, A.; Salvatori, R.; Auchus, R. J.; Feelders, R. A.; Geer, E. B.; Greenman, Y.; Witek, P.; Cohen, F.; more...
    Lancet Diabetes & Endocrinology (2019)

    Fulltext@MSK | Save
  • Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: Extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
    Journal Article

    Motzer, R. J.; Rini, B. I.; McDermott, D. F.; Arén Frontera, O.; Hammers, H. J.; Carducci, M. A.; Salman, P.; Escudier, B.; Beuselinck, B.; Amin, A.; more...
    Lancet Oncology (2019)

    Fulltext@MSK | Save
  • Effects of infrared laser moxibustion on cancer-related fatigue in breast cancer survivors: Study protocol for a randomized controlled trial
    Journal Article

    Mao, H.; Mao, J. J.; Chen, J.; Li, Q.; Chen, X.; Shen, X.; Zhao, L.; Wei, J.; Shen, X.
    Medicine (2019)

    Fulltext@MSK | Save
  • A scale for patient-reported symptom assessment for patients with Erdheim-Chester disease
    Journal Article

    Diamond, E. L.; Reiner, A. S.; Buthorn, J. J.; Shuk, E.; Applebaum, A. J.; Hyman, D. M.; Abdel-Wahab, O.; Rampal, R.; Janku, F.; Brewer, K.; more...
    Blood Advances (2019)

    Fulltext@MSK | Save
  • Life after lung cancer: Overcoming the challenges of lung cancer survivorship
    Journal Article

    Knowles, K.
    Coping With Cancer (2019)

    Fulltext@MSK | Save
  • Daily fractionation of external beam accelerated partial breast irradiation to 40 Gy is well tolerated and locally effective
    Journal Article

    Braunstein, L. Z.; Thor, M.; Flynn, J.; Cost, Z.; Wilgucki, M.; Rosenbaum, S.; Zhang, Z.; Gillespie, E.; McCormick, B.; Khan, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2019)

    Fulltext@MSK | Save